The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

Gilead Sciences’ long-acting drug to block HIV has the potential to end the AIDS epidemic worldwide. But accessibility ...

Delfi Diagnostics is combining AI and liquid biopsy tech to make routine blood tests a powerful tool against cancer —starting ...